|
4¿ù 30ÀÏ(±Ý) |
Bone ¥°(English session) - MicroRNA and Bone |
11:10~12:40 |
What is new in microRNA world? |
WY Park (SNU, Korea) |
Role of microRNA on osteoblast differentiation |
Rong Hu(Central South Univ., China) |
Practical issues related to the use of siRNAs, particularly in osteocytes and osteoblasts |
Lynda Bonewald (Univ. of Missouri, USA) |
11:10~12:40 |
Diabetes& Obesity ¥° |
Genomics (& Copy number variation) |
¼Á¤¼±(¼¿ï´ë, »ýÈÇаú) |
Genome-Wide Association Study |
Á¶À±½Å(Áúº´°ü¸®º»ºÎ) |
Gene-environmental interaction |
Knowler WC (NIH, USA) |
11:10~12:40 |
Thyroid ¥° |
Understanding of autoimmunity in Graves' disease from Graves' animal model |
Bingyin Shi(Xi¡¯an Jiaotong Univ., China) |
Autoimmune Thyroid Disease and regulatory T cell |
±èÀº¼÷(¿ï»êÀÇ´ë, ³»ºÐºñ³»°ú) |
Autoimmune Thyroid Disease in pregnancy |
ÀÓâÈÆ(°üµ¿ÀÇ´ë, ³»ºÐºñ³»°ú) |
13:50~15:20 |
Neuroendocrinology - Recent evidence on Pituitary Gland |
Adult GH deficiency |
±èº´ÁØ(°Ç¾çÀÇ´ë, ³»ºÐºñ³»°ú) |
Tumour volume monitoring on acromegalic patients who had pegvisomant treatment (German Pegvisomant Observational Study) |
Michael Buchfelder (Erlangen-Nurnberg Univ., Germany) |
New Directions in the Treatment of Cushing's Disease |
Ilan Shimon Rabin Medical Center, Israel) |
13:50~15:20 |
Vascular endocrinology ¥°- Endothelial Dysfunction and Vascular Inflammation |
Endothelial activators in angiogenesis and vascular inflammation |
±Ç¿µ±Ù(¿¬¼¼´ë, »ýÈÇаú) |
The impact of Mitochondrial Dysfunction on Endothelial Dysfunction and Vascular Inflammation |
ÀÌÀαÔ(°æºÏÀÇ´ë, ³»ºÐºñ³»°ú) |
Adipose tissue remodeling as homeostatic inflammation |
Yoshihiro Ogawa(Tokyo medical and dental Univ., Japan) |
13:50~15:20 |
Reproductive Endo ¥° |
Overview of EDC |
ÃÖ°æÈñ(±¹¸³È¯°æ°úÇпø) |
The effects of EDC on development of reproductive diseases |
Á¤Çý¿ø(ÀÌÈÀÇ´ë, »êºÎÀΰú) |
EDC and sexual maturation |
±èÈ£¼º(¿¬¼¼ÀÇ´ë, ¼Ò¾Æû¼Ò³â°ú) |
|
5¿ù 1ÀÏ(Åä) |
Bone II - Bone and Skeletal Muscle |
11:00~12:30 |
Age and Gender Difference in Bone (BMD and Geometry) and Muscle |
±è°æ¹Î(¿¬¼¼ÀÇ´ë, ³»ºÐºñ³»°ú) |
The Effects of Sex Hormones and Their Metabolites on Bone and Muscle |
Çѱâ¿Á(°üµ¿ÀÇ´ë, ³»ºÐºñ³»°ú) |
Regulation and Assessment of Muscle Mass |
¹Ú¼®¿ø(CHAÀÇ°ú´ëÇб³, ³»ºÐºñ³»°ú) |
11:00~12:30 |
DM & Obesity II - Genetics of Diabetes |
ROS signaling and insulin resistance in Liver |
äÇÑÁ¤(ÀüºÏÀÇ´ë, ¾à¸®Çб³½Ç) |
ER stress and insulin resistance in Liver |
±¸½Âȸ(¼º±Õ°üÀÇ´ë, ºÐÀÚ¼¼Æ÷»ý¹°Çб³½Ç) |
Amelioration of ER stress both in liver and pancreas by antioxidant treatment |
¹Ú¿ë¼ö(ÇѾçÀÇ´ë, ³»ºÐºñ³»°ú) |
11:00~12:30 |
Thyroid II - Thyroid Cancer |
°©»ó¼±¾ÏÀÇ pre-operative staging ¹× Ä¡·áÀü·« °áÁ¤ |
±èÀº°æ(¿¬¼¼ÀÇ´ë, ¿µ»óÀÇÇаú) |
Tumorigenesis of DTC-focused on alterations of signal pathways |
°È£Ã¶(Àü³²ÀÇ´ë, ³»ºÐºñ³»°ú) |
°©»ó¼±¾ÏÀÇ ¼ö¼úÀû Ä¡·á ¼ºÀû- PTMC (Papillary Thyroid Microcarcinoma) ¸¦ Áß½ÉÀ¸·Î - |
È«¼®ÁØ(¿ï»êÀÇ´ë, ¿Ü°ú) |
11:00~12:30 |
Adrenal Gland - Endocrine Hypertension |
Diversity of primary aldosteronism |
¹Ú¼¼Àº(¼º±Õ°üÀÇ´ë, ³»ºÐºñ³»°ú) |
Early diagnosis of endocrine hypertension |
Á¶µ¿Çõ(Àü³²ÀÇ´ë, ³»ºÐºñ³»°ú) |
Cushing syndrome associated hypertension |
¹ÚÁ¾¼÷(¿¬¼¼ÀÇ´ë, ³»ºÐºñ³»°ú) |
14:50~16:20 |
Lipid - Recent evidence on Lipid Metabolism |
HDL-C as a therapeutic target |
ÀÌ´ëÈ£(Á¦ÁÖÀÇ´ë, ³»ºÐºñ³»°ú) |
Cardiovascular characteristics of Korean subjects with low LDL-C but high hs-CRP levels |
ÀÌÀºÁ¤(¼º±Õ°üÀÇ´ë, ³»ºÐºñ³»°ú) |
CETP inhibition and cholesterol metabolism |
Á¶ÀºÁÖ(°¡Å縯ÀÇ´ë, ½ÉÀå³»°ú) |
14:50~16:20 |
Vascular Endocrinology II |
Brain vascular work up using Brain MR angio, transcranial doppler, brain angiography |
¼´ëö(¿ï»êÀÇ´ë, ¿µ»óÀÇÇаú) |
Cardiac work up using coronary angio and angio-CT |
À¯±âµ¿(°¡Å縯ÀÇ´ë, ½ÉÀå³»°ú) |
Atherosclerosis work up using PET |
Ãְ湬(°í·ÁÀÇ´ë, ³»ºÐºñ³»°ú) |
14:50~16:20 |
Aging - Endocrinology and the Life Span |
Evolution of the human lifespan and endocrine function |
±èâ¿À(¿¬¼¼ÀÇ´ë, ³»°ú) |
Role of autophagy in the endocrine diseases and aging |
À̸í½Ä(¼º±Õ°üÀÇ´ë, ³»ºÐºñ³»°ú) |
Intervention strategies in elderly vascular disease - redox-dependent transcriptional regulation of inflammatory mediators in atherosclerosis |
¿À±¸ÅÃ(ÀÌÈ¿©´ë, ½ÉÇ÷°üÀ¯ÀüüÇבּ¸½Ç) |